AriBioLabLtd's earnings have been declining at an average annual rate of -0.6%, while the Biotechs industry saw earnings growing at 15.2% annually. Revenues have been declining at an average rate of 11.7% per year.
How AriBioLabLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A261780 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
332
-15,544
1,912
11,524
31 Dec 25
159
-16,044
1,981
11,978
30 Sep 25
159
-14,251
1,831
8,993
30 Jun 25
159
-12,369
1,820
7,453
31 Mar 25
0
-11,295
1,837
6,259
31 Dec 24
371
-10,138
1,874
5,678
30 Sep 24
371
-4,260
1,968
4,975
30 Jun 24
371
-4,457
2,012
5,010
31 Mar 24
543
-1,472
2,136
4,174
31 Dec 23
294
-1,749
2,197
3,949
30 Sep 23
294
-5,029
2,327
4,425
30 Jun 23
294
-4,602
2,477
3,798
31 Mar 23
184
-6,826
2,409
4,086
31 Dec 22
179
-6,715
2,357
3,855
30 Sep 22
179
-18,877
3,513
3,406
30 Jun 22
179
-18,806
3,357
3,316
31 Mar 22
617
-18,410
3,215
3,340
31 Dec 21
500
-18,420
3,199
3,140
30 Sep 21
523
-7,014
1,731
3,039
30 Jun 21
547
-7,731
1,648
3,238
31 Mar 21
62
-7,005
1,404
3,011
31 Dec 20
78
-6,240
1,038
3,124
31 Dec 19
126
-2,980
469
2,458
31 Dec 16
173
-1,404
269
255
Quality Earnings: A261780 is currently unprofitable.
Growing Profit Margin: A261780 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A261780 is unprofitable, and losses have increased over the past 5 years at a rate of 0.6% per year.
Accelerating Growth: Unable to compare A261780's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A261780 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (22.6%).
Return on Equity
High ROE: A261780 has a negative Return on Equity (-162.06%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/23 08:10
End of Day Share Price
2026/07/23 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AriBioLab Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.